STRO
Sutro Biopharma
NASDAQ: STRO · HEALTHCARE · BIOTECHNOLOGY
$35.39
+2.02% today
Updated 2026-04-29
Market cap
$556.51M
P/E ratio
—
P/S ratio
5.43x
EPS (TTM)
$-22.49
Dividend yield
—
52W range
$7 – $36
Volume
0.2M
Sutro Biopharma (STRO) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |